This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sallinen, P. Articles by Kononen, J. Search for Related Content PubMed PubMed Citation Articles by Sallinen, P. Articles by Kononen, J.

American Journal of Pathology, Vol 150, 1159-1164, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas

P Sallinen, H Miettinen, SL Sallinen, H Haapasalo, H Helin and J Kononen
Department of Pathology, Tampere University Hospital, Finland.

Deregulation of telomerase, a ribonucleoprotein polymerase that compensates progressive loss of telomeric (TTAGGG)n repeats during DNA replication, has been suggested to facilitate tumorigenesis and cellular immortality by providing unlimited proliferation capacity for cancer cells. We investigated the relationship between tumor proliferation activity and in situ expression of the telomerase RNA component in 46 human grade I to IV astrocytomas. Heterogeneously distributed telomerase RNA expression was detected from all of the tumor samples as well as from normal human brain tissue. However, expression of telomerase RNA was significantly increased in highly malignant tumors (P = 0.024) and in tumors that showed increased proliferation activity determined by MIB-1 immunohistochemistry (P = 0.014). Interestingly, increased telomerase RNA levels were observed in a subgroup of grade II astrocytomas that showed significant increase in proliferation activity (P = 0.047), indicating that the telomerase RNA component is up-regulated already in early states of astrocytoma malignancy. Telomeric repeats amplification assays revealed telomerase activity in 4 of 6 glioblastomas and in 1 rapidly proliferating grade II astrocytoma. These results suggest that increased tumor proliferation activity triggers telomerase activation via mechanisms that involve increased production of the telomerase RNA component.

This article has been cited by other articles:

				V. Rohde, H.-P. Sattler, T. Bund, H. Bonkhoff, T. Fixemer, C. Bachmann, R. Lensch, G. Unteregger, M. Stoeckle, and B. Wullich Expression of the Human Telomerase Reverse Transcriptase Is Not Related to Telomerase Activity in Normal and Malignant Renal Tissue Clin. Cancer Res., December 1, 2000; 6(12): 4803 - 4809. [Abstract] [Full Text]

				B. Heine, S. E Coupland, S. Kneiff, G. Demel, N. Bornfeld, M. Hummel, and H. Stein Telomerase expression in uveal melanoma Br. J. Ophthalmol., February 1, 2000; 84(2): 217 - 223. [Abstract] [Full Text]

				P. Yan, J.-M. Coindre, J. Benhattar, F. T. Bosman, and L. Guillou Telomerase Activity and Human Telomerase Reverse Transcriptase mRNA Expression in Soft Tissue Tumors: Correlation with Grade, Histology, and Proliferative Activity Cancer Res., July 1, 1999; 59(13): 3166 - 3170. [Abstract] [Full Text] [PDF]

				K. Nakano, E. Watney, and J. K. McDougall Telomerase Activity and Expression of Telomerase RNA Component and Telomerase Catalytic Subunit Gene in Cervical Cancer Am. J. Pathol., September 1, 1998; 153(3): 857 - 864. [Abstract] [Full Text] [PDF]